Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel
NGS-based targeted sequencing in CSF has the potential to facilitate brain tumor diagnosis in patients presenting with new cerebral lesions.
Authors
- M. Nowak
- Nils Briel (ORCID: https://orcid.org/0000-0002-4349-3277)
- Alexander Köpp
- T. Weiss
- H. Moch
- E. Le Rhun
- M. R. Schmid
- Peter Westarp
- Michael Weller
- Martin Zoche
- Roger Schenk
- Adela Brzobohata
- Maximilian Mastall
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf270
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00